These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15549130)

  • 1. Pharmacogenomics in admixed populations: the Brazilian pharmacogenetics/pharmacogenomics network--REFARGEN.
    Suarez-Kurtz G
    Pharmacogenomics J; 2004; 4(6):347-8. PubMed ID: 15549130
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advances in research on pharmacogenomics].
    Hua YF; Ming ZH; Zhang M
    Yao Xue Xue Bao; 2002 Aug; 37(8):668-72. PubMed ID: 12567787
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in pharmacogenomics and its promise for medicine.
    Blake CA; Sobel BE
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informed consent in pharmacogenomics.
    Licinio J; Wong ML
    Pharmacogenomics J; 2002; 2(6):343-4. PubMed ID: 12629498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacogenomics: way to individual therapy].
    Piruzian AL
    Eksp Klin Farmakol; 2005; 68(5):59-67. PubMed ID: 16277215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics: questions and concerns.
    Mahlknecht U; Voelter-Mahlknecht S
    Curr Med Res Opin; 2005 Jul; 21(7):1041-7. PubMed ID: 16004671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics and the future of drug therapy.
    Hines RN; McCarver DG
    Pediatr Clin North Am; 2006 Aug; 53(4):591-619. PubMed ID: 16872995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ethical implications of stratifying by race in pharmacogenomics.
    Lee SS
    Clin Pharmacol Ther; 2007 Jan; 81(1):122-5. PubMed ID: 17186010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics in drug development: societal and technical aspects.
    Bartfai T
    Pharmacogenomics J; 2004; 4(4):226-32. PubMed ID: 15123996
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacogenomics - a promise in clinical practice].
    Bredeţean O; Ciochină AD
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):7-10. PubMed ID: 12089963
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of data privacy could hamper pharmacogenomics studies.
    Howard K
    Nat Rev Drug Discov; 2004 Sep; 3(9):725. PubMed ID: 15368651
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring the value of pharmacogenomics.
    Phillips KA; Van Bebber SL
    Nat Rev Drug Discov; 2005 Jun; 4(6):500-9. PubMed ID: 15915153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics: from bedside to clinical practice.
    Marsh S; McLeod HL
    Hum Mol Genet; 2006 Apr; 15 Spec No 1():R89-93. PubMed ID: 16651374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Conference on Harmonisation; Guidance on E15 Pharmacogenomics Definitions and Sample Coding; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Apr; 73(68):19074-6. PubMed ID: 18677821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.
    Russo A; Corsale S; Cammareri P; Agnese V; Cascio S; Di Fede G; Macaluso M; Bazan V
    J Cell Physiol; 2005 Sep; 204(3):742-9. PubMed ID: 15828025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Darwinism and pharmacogenomics: from 'one treatment fits all' to 'selection of the richest'?
    Voelter-Mahlknecht S; Mahlknecht U
    Trends Mol Med; 2004 May; 10(5):208-9. PubMed ID: 15121046
    [No Abstract]   [Full Text] [Related]  

  • 18. Planning for a national effort to enable and accelerate discoveries in pharmacogenetics: the NIH Pharmacogenetics Research Network.
    Long RM
    Clin Pharmacol Ther; 2007 Mar; 81(3):450-4. PubMed ID: 17339874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospect for pharmacogenomics in the interferon therapy of chronic viral hepatitis.
    Yeh SH; Chen DS; Chen PJ
    J Antimicrob Chemother; 2003 Aug; 52(2):149-51. PubMed ID: 12837727
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomics in Japan.
    Tamaoki M; Gushima H; Tsutani K
    Pharmacogenomics J; 2004; 4(5):288-90. PubMed ID: 15224084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.